1. Home
  2. LSE vs IMUX Comparison

LSE vs IMUX Comparison

Compare LSE & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leishen Energy Holding Co. Ltd. Ordinary Shares

LSE

Leishen Energy Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$4.76

Market Cap

87.7M

Sector

Industrials

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.68

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSE
IMUX
Founded
2007
2016
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.7M
85.8M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
LSE
IMUX
Price
$4.76
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$6.00
AVG Volume (30 Days)
6.0K
1.7M
Earning Date
09-30-2025
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$57,385,142.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$31.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.03
$0.51
52 Week High
$14.99
$1.39

Technical Indicators

Market Signals
Indicator
LSE
IMUX
Relative Strength Index (RSI) 57.80 57.63
Support Level $4.03 $0.64
Resistance Level $4.88 $0.72
Average True Range (ATR) 0.31 0.05
MACD 0.08 0.02
Stochastic Oscillator 100.00 84.72

Price Performance

Historical Comparison
LSE
IMUX

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: